Declaration of Competing Interest statements were not included in the published version of the following articles that appeared in previous issues of Contemporary Clinical Trials Communications.
The appropriate Declaration/Competing Interest statements, provided by the Authors, are included below.
-
1.
“Examining conscious motor processing and the effect of single-task, dual-task and analogy training on walking during rehabilitation by older adults at risk of falling in Hong Kong: Design and methodology of a randomized controlled trial” [Contemporary Clinical Trials Communications, 2019; 15: 100398]
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
2.
“Feasibility and preliminary efficacy of Ai Chi aquatic exercise training in Hong Kong's older adults with risk of falling: Design and methodology of a randomized controlled trial” [Contemporary Clinical Trials Communications, 2019; 15: 100376] https://doi.org/10.1016/j.conctc.2019.100376
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
3.
“Do Social Cognitive Theory constructs explain response heterogeneity with a physical activity behavioral intervention in multiple sclerosis?” [Contemporary Clinical Trials Communications, 2019; 15: 100366]
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
4.
“A randomized controlled trial of exercise to prevent muscle mass and functional loss in elderly hemodialysis patients: Rationale, study design, and baseline sample” [Contemporary Clinical Trials Communications, 2019; 15: 100365]
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
5.
“Culturally-tailored text-messaging intervention for smoking cessation in rural American Indian communities: Rationale, design, and methods” [Contemporary Clinical Trials Communications, 2019; 15: 100363]
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
6.
“A protocol to develop and study the effectiveness and implementation of social skills training that improves supported housing retention for persons with serious mental illness” [Contemporary Clinical Trials Communications, 2019; 15: 100344] https://doi.org/10.1016/j.conctc.2019.100344
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
7.
“Study protocol for a randomized trial evaluating the effect of a “birth environment room” versus a standard labour room on birth outcomes and the birth experience” [Contemporary Clinical Trials Communications, 2019; 14: 100336]
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
8.
“A regression based phase I clinical trial for late-onset toxicities without clinician elicitation” [Contemporary Clinical Trials Communications, 2019; 14: 100327] https://doi.org/10.1016/j.conctc.2019.100327
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
9.
“Sample size estimation and re-estimation of cluster randomized controlled trials for real-time feedback, debriefing, and retraining system of cardiopulmonary resuscitation for out-of-hospital cardiac arrests” [Contemporary Clinical Trials Communications, 2019; 14: 100316] https://doi.org/10.1016/j.conctc.2019.100316
Declaration of competing interest: This work was supported by the Grants-in-aid for Scientific Research-KAKENHI-Scientific Research (B) [grant number 15H05006]; and donations to KYOTO University Health Service; no author received any personal stipend or any other benefit. ZOLL Medical Corporation supplied the CPR feedback devices use for this trial.
-
10.
“Investigating the efficacy of a self-directed parenting intervention to reduce risky behaviors among college students: Study protocol for a multi-arm hybrid type 2 randomized control trial” [Contemporary Clinical Trials Communications, 2020; 14: 100627] https://doi.org/10.1016/j.conctc.2020.100627
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
11.
“Protocol for a multicenter randomized, double blind, controlled pilot trial of higher neural function in overactive bladder patients after anticholinergic, beta-3 adrenergic agonist, or placebo” [Contemporary Clinical Trials Communications, 2020; 19: 100621] https://doi.org/10.1016/j.conctc.2020.100621
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
12.
“Lessons learned from two randomized controlled trials: CITIES and STOP-DKD” [Contemporary Clinical Trials Communications, 2020; 19: 100612]
Declaration of competing interest: Dr. Bosworth reports research grants from the PhRMA Foundation, Proteus Digital Health, Otsuka, Novo Nordisk, Sanofi, Improved Patient Outcomes, Boehinger Ingelheim, NIH, and VA as well as consulting from Sanofi, Novartis, Otsuka, Abbott, Xcenda, Preventric Diagnostics, and the Medicines Company.
-
13.
“The promotion of physical activity for the prevention of Alzheimer's disease in adults with Down Syndrome: Rationale and design for a 12Â Month randomized trial” [Contemporary Clinical Trials Communications, 2020; 19: 100607]
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
14.
“An evaluation of quadratic inference functions for estimating intervention effects in cluster randomized trials” [Contemporary Clinical Trials Communications, 2020; 19: 100605] https://doi.org/10.1016/j.conctc.2020.100605
Declaration of competing interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
-
15.
“A randomized controlled trial comparing intensive non-surgical treatment with bariatric surgery in adolescents aged 13–16 years (AMOS2): Rationale, study design, and patient recruitment” [Contemporary Clinical Trials Communications, 2020; 19: 100592] https://doi.org/10.1016/j.conctc.2020.100592
Declaration of competing interest: Kajsa Järvholm has received personal fees from NovoNordisk and Merck